Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company, today announced its intention to offer and sell shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE